The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
History of Antibiotics Research
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural products as sources of new drugs from 1981 to 2014
Newman, D. J., & Cragg, G. M. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b01055 · Cited by 5,858
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Drug Discovery: A Historical Perspective
Drews, J. (2000) · Science · doi:10.1126/science.287.5460.1960 · Cited by 2,760
Natural products in drug discovery
Harvey, A. L. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.07.004 · Cited by 1,832
Fleming, A. (1929) · PubMed Central · Cited by 1,647
A brief history of the antibiotic era: lessons learned and challenges for the future
Aminov, R. I. (2010) · Frontiers in Microbiology · doi:10.3389/fmicb.2010.00134 · Cited by 1,628
Platforms for antibiotic discovery
Lewis, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3975 · Cited by 1,445
An Enzyme from Bacteria able to Destroy Penicillin
ABRAHAM, E. P., & CHAIN, E. (1940) · Nature · doi:10.1038/146837a0 · Cited by 1,333
DNA gyrase: an enzyme that introduces superhelical turns into DNA.
Gellert, M., Mizuuchi, K., O'Dea, M. H., & Nash, H. A. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.11.3872 · Cited by 1,204
Research works printed but not linked: 62
- Baltz RH (1998) Genetic manipulation of antibiotic producing Streptomyces. Trends Microbiol 2:76–83 · doi:10.1016/s0966-842x(97)01161-x
- Bange F-C, Fille M (2012) Antimykobakterielle therapie chapter 105. In: Suerbaum S, Hahn H, Burchard G-D, Kaufmann SHE, Schulz TF (eds) Medizinische Mikrobiologie und Infektiologie 7 Auflage Springer, Berlin · doi:10.1007/978-3-642-24167-3_105
- Bange F-C, Hahn H, Kaufmann SHE, Ulrichs T (2012) Mykobakterien. Chapter 41. In: Suerbaum S, Hahn H, Burchard G-D, Kaufmann SHE, Schulz TF (eds) Medizinische Mikrobiologie und Infektiologie 7 Auflage. Springer, Berlin
- Béchamp MA (1863) De l’action de la chaleur sur l’arseniate d’analine et de la formation d’un anilide de l’acide arsenique. Compt Rend 56:1172–1175
- Bennett JW (2015) What is an antibiotic? In: Sánchez S, Demain AL (eds) Antibiotics-current innovations and future trends. Caister Academic Press · doi:10.21775/9781908230546.01
- Berger A, Fingerle V, Sing A (2012) Treponemen. Chapter 43. In: Suerbaum S, Hahn H, Burchard G-D, Kaufmann SHE, Schulz TF (2012) Medizinische Mikrobiologie und Infektiologie. 7. Auflage. Springer, Berlin · doi:10.1007/978-3-642-24167-3_43
- Bloemendal S, Kück U (2014) Cephalosporins. In: Martín JF, García-Estrada C, Zeilinger S (eds) Biosynthesis and molecular genetics of fungal secondary metabolites. Springer, New York, pp 43–64 · doi:10.1007/978-1-4939-1191-2_3
- Brewer GA, Johnson MJ (1953) Activity and properties of para-aminobenzyl penicillin. Appl Microbiol 1:163–166 · doi:10.1128/am.1.4.163-166.1953
- Burris RH, Baumann A, Potter VR (1990) Conrad Arnold Elvehjem. Biographical memoir, Nat Acad Sc
- Charlebois A, Jalbert LA, Harel J, Masson L, Archambault M (2012) Characterization of genes encoding for acquired bacitracin resistance. Clostridium perfringens PloS One 7(9). doi:10.1371 · doi:10.1371/journal.pone.0044449
- Controulis J, Rebstock MC, Crooks HM (1949) Chloramphenicol (Chloromycetin). V. Synthesis. J Am Chem Soc 71:2463–2468 · doi:10.1021/ja01175a066
- Dubos RJ, Hotchkiss RD (1942) Origin, nature and property of gramicidin and tyrocidine. Trans Studies Coll Phys Phila 4(10):11–19
- Dubos RJ, Hotchkiss RD, Coburn AF (1942) The effect of gramicidin and tyrocidine on bacterial metabolism. J Biol Chem 146:421–426 · doi:10.1016/s0021-9258(18)44961-7
- Duckett S (1999) Ernest Duchesne and the concept of fungal antibiotic therapy. Lancet 11(354):2068–2071 · doi:10.1016/s0140-6736(99)03162-1
- Ehrlich P, Bertheim A (1912): Über das salzsaure 3.3-Diamino-4.4-dioxy-arsenobenzol und seine nächsten Verwandten. Berichte der deutschen chemischen Gesellschaft Bd 45(1):756–766 · doi:10.1002/cber.191204501110
- Ehrlich J, Gottlieb D, Burkholder PR, Anderson LE, Pridham TG (1948) Streptomyces venezuelae, N. sp., The source of chloromycetin. J Bacteriol 56:467–477 · doi:10.1128/jb.56.4.467-477.1948
- Ferber D (2003) Triple-threat microbe gained powers from another bug. Science 302:1488 · doi:10.1126/science.302.5650.1488
- Gelmo P (1908) Über Sulfamide der p-Amidobenzolsulfonsäure. J prak Chem 77:369–382 · doi:10.1002/prac.19080770129
- Gosio B (1896) Ricerdre batteriologische chirmide sulle alterazioni del mais. Rivista d’Ingienne e Sanita Publica 7:825–868
- Gottlieb D, Bhattacharyya PK, Anderson HW, Carter HE (1948) Some properties of an antibiotic from a species of Streptomyces. J Bact 55:409–417 · doi:10.1128/jb.55.3.409-417.1948
- Griesgraber G, Or YS, Chu DTW, Nilius AM, Johnson PM, Flamm RK, Henry RF, Plattner JJ (1996) 3-Keto-11, 12-carbazate Derivatives of 6-O-Methylerythromycin A synthesis and in vitro activity. J Antibiot 49:465–477 · doi:10.7164/antibiotics.49.465
- Grohe K, Heitzer H (1987) Cycloaracylierung von Enaminen, I Synthese von 4-Chinolon-3-carbonsauren. Lieb Ann Chem 1:29–37 · doi:10.1002/jlac.198719870106
- Grohe K, Zeiler HJ, Metzger K (1981) 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, Verfahren zu ihrer Herstellung sowie diese enthaltende antibakterielle Mittel. DE 3142854:A1
- Guttmann P, Ehrlich P (1891) Über die Wirkung des Methylenblau bei Malaria. Berl Klin Wochenschr 28:953–956
- Harris DA, Reagan MA, Ruger M, Wallick H, Woodruff HB (1955) Discovery and antimicrobial properties of cathomycin, a new antibiotic produced by Streptomyces spheroides n. sp. Antibiot Annu 3:909–917
- Hawgood BJ (2008) Alexandre Yersin (1863–1943): discoverer of the plague bacillus, explorer and agronomist. J Med Biog 16:167–172 · doi:10.1258/jmb.2007.007017
- Heide L (2014) New aminocoumarin antibiotics as gyrase inhibitors. Int J Med Microbiol 304:31–36 · doi:10.1016/j.ijmm.2013.08.013
- Herrmann J, Lukežič T, Kling A, Baumann S, Hüttel S, Petković H, Müller R (2016) Strategies for the discovery and development of new antibiotics from natural products: three case studies. Curr Top Microbiol Immunol Springer EBook · doi:10.1007/82_2016_498
- Hesterkamp T (2015) Antibiotics clinical development and pipeline. Curr Top Microbiol Immunol. (Springer EBook). doi:10.1007/82_2015_451 · doi:10.1007/82_2015_451
- Höck M (2012a) Glycopeptidantibiotika. Chapter 98. Suerbaum S, Hahn H, Burchard G-D, Kaufmann SHE, Schulz TF (eds) Medizinische Mikrobiologie und Infektiologie 7 Auflage. Springer, Berlin
- Höck M (2012b) Makrolide. Chapter 102. Suerbaum S, Hahn H, Burchard G-D, Kaufmann SHE, Schulz TF (eds) Medizinische Mikrobiologie und Infektiologie 7. Auflage. Springer, Berlin · doi:10.1007/978-3-642-24167-3_102
- Hollstein U (1973) Actinomycin. chemistry and mechanism of action. Chem Rev 6:625–652
- Hotchkiss RD, Dubos RJ (1940a) Fractionation of bactericidal agent from cultures of a soil bacillus. J Biol Chem 132:791–792 · doi:10.1016/s0021-9258(19)56231-7
- Hotchkiss RD, Dubos RJ (1940b) Chemical properties of bactericidal substances isolated from cultures of a soil bacillus. J Biol Chem 132:793–794 · doi:10.1016/s0021-9258(19)56232-9
- Jacoby GA, Bush K (2005) Beta-lactam resistance in the 21st century. In: White DG, Alekshun MN, McDermott PF (eds) Frontiers in antimicrobial resistance. ASM Press, Washington, DC, pp 53–65 · doi:10.1128/9781555817572.ch5
- Jäger H (2011) Cinchona pubescens. In: Roloff, A., Weisgerber, H., Lang, U., Stimm, B. (Hrsg.): Enzyklopädie der Holzgewächse, Wiley-VCH, Weinheim, 58:1–14
- Khosla R, Verma DD, Kapur A, Aruna RV, Khanna N (1999) Streptogramins: a new class of antibiotics. Indian J Med Sci 53:111–119
- Klein P, Falke D, Hahn H (2012) Ursprung der medizinischen Mikrobiologie. Chapter 2. In: Suerbaum S, Hahn H, Burchard G-D, Kaufmann SHE, Schulz TF (eds) Medizinische Mikrobiologie und Infektiologie. 7. Auflage. Springer, Berlin · doi:10.1007/978-3-642-24167-3_2
- Lewis C, Clapp HW, Grady JE (1962) In vitro and in vivo evaluation of lincomycin, a new antibiotic. Antimicrob Agents Chemother 2:570
- Lippi D, Conti AA (2002) Plague, policy, saints and terrorists: a historical survey. J Infect 44(4):226–228 · doi:10.1053/jinf.2002.0995
- Majno G, Joris I (1979) Billroth and Penicillium. Rev Infect Dis 5:880–884 · doi:10.1093/clinids/1.5.880
- Mason DJ, Dietz A, Deboer C (1962) Lincomycin-a new antibiotic. I. Discovery and biological properties AAC 2:554–559
- Meyers BR, Kaplan K, Weinstein L (1969) Micro- biological and pharmacological behaviour of 7-chloro- lincomycin. Appl Microbiol 17:653 · doi:10.1128/am.17.5.653-657.1969
- Neufeldt S (2003) Chronologie Chemie: Entdecker und Entdeckungen Ed. Neufeldt S. 3. Auflage Wiley VCH
- Newton GGF, Abraham EP (1955) Cephalosporin C, a new antibiotic containing sulphur and D-aminoadipic acid. Nature 175:548 · doi:10.1038/175548a0
- No authors listed (1967) Gentamicin. Br Med J 21:158–159
- Pandit N, Singla RK, Shrivastava B (2012) Current updates on oxazolidinone and its significance. Int J Med Chem. doi:10.1155/2012/159285 · doi:10.1155/2012/159285
- Parenti F, Beretta G, Berti M, Arioli V (1978) Teicomycins, new antibiotics from Actinoplanes teicomyceticus nov. sp. I. Description of the producer strain, fermentation studies and biological properties. J Antibiot 31:276–283 · doi:10.7164/antibiotics.31.276
- Smith RM, Joslyn DA, Gruhzit OM, McLean W, Penner MA, Ehrlich J (1947) Chloromycetin: biological studies · doi:10.1128/jb.55.3.425-448.1948
- Spoerer M, Streb J (2013) Neue deutsche Wirtschaftsgeschichte des 20. Walter de Gruyter, Jahrhunderts · doi:10.1524/9783486766561
- Stahlmann R, Riecke K (2004) Die Infektiologie. 5.3.14.1 Editors: Adam D, Doerr HW, Link H, Lode H (Hrsg.), Springer
- Takeuchi T, Hikiji T, Nitta K, Yamazaki S, Abe S, Takayama H, Umezawa H (1957) Biological studies on kanamycin. J Antibiot (Tokyo) 10:107–114
- Thomas HW (1905) Some experiments in the treatment of trypanosomiasis. Brit Med J 1140 · doi:10.1136/bmj.1.2317.1140
- Tréfouël J and T, Nitti F, Bovet D (1935) Activité du p-aminophénylsulfamide sur l’infection streptococcique expérimentale de la souris et du lapin. C R Soc Biol 120(23):756
- Waksman SA (1947) What is an antibiotic or an antibiotic substance? Mycologia 39:565–569 · doi:10.2307/3755196
- Waksman SA, Lechevalier HA, Harris DA (1949) Neomycin-production and antibiotic properties. J Clin Invest 28:934–939 · doi:10.1172/jci102182
- Waksman SA, Lechevalier HA (1949) Neomycin, a new antibiotic active against streptomycin-resistant bacteria, including tuberculosis organisms. Science 25:305–307 · doi:10.1126/science.109.2830.305
- Weber T, Welzel K, Pelzer S, Vente A, Wohlleben W (2003) Exploiting the genetic potential of polyketide producing streptomycetes. J Biotechnol 106:221–232 · doi:10.1016/j.jbiotec.2003.08.004
- Weiss HJ, Rogers J, Brand H (1973) Defective ristocetin-induced platelet aggregation in von Willebrand’s disease and its correction by factor VIII. J Clin Invest 52:2697–2707 · doi:10.1172/jci107464
- Woodward RB, Doering WE (1945) The total synthesis of quinine. J. Amer Chem Soc 67:860–874 · doi:10.1021/ja01221a051
- Würth I (2012) Geißler in Thüringen: Die Entstehung einer spätmittelalterlichen Häresie (Hallische Beiträge zur Geschichte des Mittelalters und der Frühen Neuzeit, Band 10 · doi:10.1524/9783050057910
- Zimdahl RL (2015) Six chemicals that changed agriculture. 1st edn. Academic Press Elsevier · doi:10.1016/b978-0-12-800561-3.00001-8
Cited by
Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects
Uddin, T. M., Chakraborty, A. J., Khusro, A., Zidan, B. R. M., Mitra, S., Emran, T. B., Dhama, K., Ripon, M. K. H., Gajdács, M., Sahibzada, M. U. K., et al. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.10.020 · Cited by 1,311
Plant-Derived Anticancer Compounds as New Perspectives in Drug Discovery and Alternative Therapy
Dehelean, C. A., Marcovici, I., Soica, C., Mioc, M., Coricovac, D., Iurciuc, S., Cretu, O. M., & Pinzaru, I. (2021) · Molecules · doi:10.3390/molecules26041109 · Cited by 502
Hossain, T. J. (2024) · European Journal of Microbiology and Immunology · doi:10.1556/1886.2024.00035 · Cited by 392
The Microbiota–Gut–Brain Axis and Alzheimer’s Disease: Neuroinflammation Is to Blame?
Megur, A., Baltriukienė, D., Bukelskienė, V., & Burokas, A. (2020) · Nutrients · doi:10.3390/nu13010037 · Cited by 323
Coque, T. M., Cantón, R., Pérez-Cobas, A. E., Fernández-de-Bobadilla, M. D., & Baquero, F. (2023) · Microorganisms · doi:10.3390/microorganisms11041050 · Cited by 258
Antibiotic pollution and associated antimicrobial resistance in the environment
Barathe, P., Kaur, K., Reddy, S., Shriram, V., & Kumar, V. (2024) · Journal of Hazardous Materials Letters · doi:10.1016/j.hazl.2024.100105 · Cited by 257
Drug repurposing to fight colistin and carbapenem-resistant bacteria
Peyclit, L., Baron, S. A., & Rolain, J.-M. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00193 · Cited by 91
Verdial, C., Serrano, I., Tavares, L., Gil, S., & Oliveira, M. (2023) · Biomedicines · doi:10.3390/biomedicines11041221 · Cited by 71
Narrative review on potential role of gut microbiota in certain substance addiction
Qin, C., Hu, J., Wan, Y., Cai, M., Wang, Z., Peng, Z., Liao, Y., Li, D., Yao, P., Liu, L., et al. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110093 · Cited by 32
Metadata
- Authors
- Mohr, K. I.
- Venue
- Current Topics in Microbiology and Immunology
- Publisher
- Springer International Publishing
- Published
- 2016
- Volume
- 398
- Pages
- 237-272
- ISSN
- 0070-217X (ISSN-L)
- 2196-9965
- OpenAlex
- W2530012524
- Cited by
- 287
- References
- 82
- FWCI
- 43.10
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.